🔎 Trials Near Me

홈 › 위암 › 미시간

미시간의 위암 임상 시험

위암 관련 연구 35개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.

미시간의 도시

공식 연구 텍스트(영어)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
  • 외 50개
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • 외 68개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06760819

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

  • Henry Ford Health, Detroit
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07700979

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

  • Research Site, North Shores
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07069712

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Grand Rapids
피험자 모집 중2상
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Barbara Ann Karmanos Cancer Institute, Detroit
  • BAMF Health Inc., Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Barbara Ann Karmanos Cancer Institute, Detroit
  • BAMF Health Inc., Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Karmanos Cancer Institiute, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • University of Michigan, Ann Arbor
  • Henry Ford Cancer Institute, Detroit
  • START - Midwest Cancer Research Center, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, Grand Rapids
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07431281

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Henry Ford Cancer Institute-Downriver, Brownstown
  • Henry Ford Health Center - Brownstown, Brownstown
  • Henry Ford Health Center - Chesterfield, Chesterfield
  • 외 13개
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  • Brigitte Harris Cancer Pavilion BHCP, Detroit
  • START Midwest, LLC, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  • University of Michigan Comprehensive Cancer Center Michigan Medicine, Ann Arbor
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06731478

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Henry Ford Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT04198766

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #120, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • Karmanos Cancer Institute, Detroit
  • Karmanos Cancer Institute, Farmington Hills
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Henry Ford Health System, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 15. 업데이트됨 · NCT06657144

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

  • University of Michigan Rogel Cancer Center, Ann Arbor
피험자 모집 중4상
18세 이상 · 여성 · 2026. 7. 2. 업데이트됨 · NCT05183126

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

  • START Midwest /ID# 248685, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT05005403

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

  • BAMF Health, Grand Rapids
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT07219238

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  • University of Michigan, Ann Arbor
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT05768932

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

  • Research Site, Grand Rapids
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 14. 업데이트됨 · NCT05702229

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

  • Henry Ford Cancer-Detroit, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 12. 19. 업데이트됨 · NCT06065371

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Ann Arbor
  • Massive Bio SYNERGY-AI site, Lansing
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • University of Michigan, Ann Arbor
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • BAMF Health, Inc., Grand Rapids
피험자 모집 중1/2상
15세 이상 · 모든 성별 · 2025. 8. 12. 업데이트됨 · NCT06298916

A Beta-only IL-2 ImmunoTherapY Study

  • Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 7. 9. 업데이트됨 · NCT05086692

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.